
Dr. Neal ElAttrache
Dr. Neal ElAttrache is one of the world’s most respected orthopedic surgeons and sports medicine specialists, recognized globally for treating elite athletes, professional sports organizations, and…
Fifteen+ years of research. Six human trials.
One remarkable cell.
After moderate to severe stroke, 40% of patients reached functional independence at 12 weeks after one IV dose, against 10% on placebo.
Niizuma 2023 · J Cereb Blood Flow Metab · randomized, double-blind, placebo-controlled · n=35
After cervical spinal cord injury with complete motor paralysis, motor scores rose an average of 15.4 points over a year after one IV dose.
In a preclinical knee-defect study, Dezawa MuseCells® were the only group to repair the defect significantly better than both control and the rest of the MSC population.
For the medical staff behind the world's most physically demanding professions.
Pro sport
This recurring loss reflects missed games and reduced performance. Orthopedic outcomes are now followed in the Registry of Outcomes of Dezawa MuseCells®.
IV administration has been studied in the published human trials. In preclinical studies, IV Dezawa MuseCells® were demonstrated to travel past the lungs to the site of injured tissue.
Kuroda 2022 · Front Pharmacol · review; Yamada 2018 · Circ Res
Local injection has long been used in the field and is now being studied with Dezawa MuseCells®. Patients treated with Dezawa MuseCells® can join the registry and add their outcomes to the research.
The Registry of Outcomes of Dezawa MuseCells® follows patients after treatment.

Dr. Neal ElAttrache is one of the world’s most respected orthopedic surgeons and sports medicine specialists, recognized globally for treating elite athletes, professional sports organizations, and…

Troy Aikman is a Pro Football Hall of Fame quarterback, broadcaster, and entrepreneur best known for leading the Dallas Cowboys during their dominant run in the 1990s.

Dr. Jonathan L. Glashow is a distinguished board-certified orthopedic surgeon with over four decades of clinical and surgical experience, widely recognized for his expertise in sports medicine and complex joint care.

As the Senior Vice President (SVP) of the UFC Performance Institute since 2017, Duncan is responsible for directing high performance services to over 700 world-class MMA fighters globally and managing…

Andy O’Brien is a strength and conditioning coach with three decades of experience in professional and Olympic sport.

Dr. Ethan Kellum is a sports medicine fellowship-trained orthopedic surgeon leading the advancement of interventional and regenerative orthopedics in the Greater Nashville area.

Gunnar Peterson is a Nashville-based personal trainer whose clients include celebrities, professional athletes, and everyday people. Gunnar is the former Los Angeles Lakers’ Director of Strength and Endurance.

Dr. Christopher C. Dodson is head of Orthopedics at the world renowned Vincera Institute in Philadelphia, Pennsylvania.

Dr. Roedl is a board-certified, fellowship-trained Interventional Musculoskeletal Radiologist specializing in the diagnosis and treatment of orthopedic conditions using advanced regenerative techniques.

Retired U.S. Army Command Sergeant Major with 28 years of experience leading elite, high-performance organizations within U.S. Army Special Operations.

Erwin started his post education career in the US Army serving 26 years and culminating his career as Chief of Staff of the US Army Special Operations Command.

Kenneth Ford is Founder and Chief Executive Officer of the Florida Institute for Human & Machine Cognition (IHMC) — a not-for-profit research institute located in Pensacola, Florida.

Alexander R. Oliver is a retired Navy SEAL with over 21 years of distinguished service, including leadership roles at the Naval Special Warfare Development Group (NSWDG) where he selected, trained and…

Ed Sanders joined Rolls-Royce Nuclear Submarines in 2023. His first substantive role was as Head of Security and Resilience within the Licence Authority Team.

Sebastien Bouchard is a former Special Operations Forces operator and founding member of the Canadian Special Operations Regiment (CSOR).

Daniel Corbett is a former U.S. Navy SEAL operator who served with elite units including SEAL Teams 5, 6, and 17.

Kevin Serre, PH.D., is the President of Dezawa High Performance™ (DHP), a wholly owned subsidiary of MuseCell Innovations® PTD LTD.

Dominik Duscher MD PhD is a specialist in longevity medicine and plastic surgery, a scientist, bestselling author, consultant, and entrepreneur.
Dezawa MuseCells® are authentic Muse cells, discovered by Professor Mari Dezawa at Tohoku University in 2010. Distinct from mesenchymal stem cells — single-positivity for SSEA-3, pluripotent-like, endogenous to connective tissue. Backed by 170+ peer-reviewed publications across global research institutions and 15+ years of independent validation.
“Muse cells” — generic — is the scientific field: the cell type described in the published research, studied by research groups worldwide.
Dezawa MuseCells® is the authentic clinical product: Muse cells prepared under license from MuseCell Innovations®, the global IP owner for the technology.
The science travels with the authentic cell. So does the safety.
Every authentic preparation is verified for SSEA-3 identity and ships with a lot-specific Certificate of Analysis. Authentic Dezawa MuseCells® are distributed only through MuseCell Innovations, the global IP owner, and its authorized healthcare centers.
If you administer cell therapy, your patients associate the outcome with your practice — not with your supplier. The reputation in the room is yours; so are the professional obligations.
Muse cells are stem cells that occur naturally in the body, in bone marrow and connective tissue. They were discovered by Professor Mari Dezawa at Tohoku University in 2010. Dezawa MuseCells® are the authentic Muse cells, licensed by the global IP owner.
‘Muse’ stands for multilineage-differentiating stress-enduring: the 2010 discovery paper reported cells that can give rise to all three germ layers and survive cellular stress.
Ordinary MSCs mostly send repair signals. In preclinical studies, Dezawa MuseCells® home to injured tissue, engulf damaged cells and take on their markers, and carry HLA-G, a tolerance molecule.
Yes, Dezawa MuseCells® have been studied in six published human trials: stroke, spinal cord injury, heart attack, ALS, newborn brain injury and a rare skin disease.
The Registry of Outcomes of Dezawa MuseCells® follows patients after treatment. Only patients treated with authentic Dezawa MuseCells® can take part.
These products have not been evaluated or approved by the United States Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure, or prevent any disease or medical condition. In the United States, certain states permit the provision of certain stem cell therapies not approved by the FDA. Currently, the states of Florida, Georgia, Tennessee, and Utah, and Texas permit the provision of certain stem cell therapies, including Muse Cells, provided the various conditions of a particular state’s requirements are met. Any clinical use is at the sole discretion of a licensed healthcare provider and must comply with all applicable laws and regulations. Individual patient results may vary. No claims are made regarding safety or effectiveness for any specific clinical application.
Dezawa High Performance™ does not promote or offer direct-to-consumer treatments. All clinical use of Dezawa MuseCells® must occur under licensed, ethics-reviewed, and jurisdictionally approved frameworks. This site is intended for institutional, clinical, and scientific audiences only. All published information utilizes Dezawa MuseCells® that are manufactured in accordance with MCI’s patented processes.
By continuing, you confirm that you have read and understood this notice.